Skip to main content
logo
Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.400
-0.080 (-5.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4355655392,6271,8534,521
Market Cap Growth
-2.74%4.80%-79.49%41.76%-59.02%-9.36%
Enterprise Value
865.27987.57821.292,9292,0274,431
Last Close Price
1.401.871.839.818.1820.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.723.533.5013.1014.4434.64
PB Ratio
183.73105.561.063.753.295.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.416.175.3314.6015.8033.95

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
297.17131.241.311.321.671.20
Net Debt / Equity Ratio
180.6579.060.560.430.31-0.11
Net Debt / EBITDA Ratio
-3.59-2.47-0.65-0.96-0.590.45
Net Debt / FCF Ratio
-3.68-3.71-1.33-1.13-0.620.77
Asset Turnover
0.200.160.100.110.070.11
Inventory Turnover
1.982.021.862.722.093.67
Quick Ratio
4.674.326.307.033.0014.90
Current Ratio
5.655.157.487.813.2415.36
Return on Equity (ROE)
-3333.14%-213.45%-51.30%-48.53%-46.42%-32.18%
Return on Assets (ROA)
-17.12%-54.21%-31.59%-18.36%-16.28%-11.46%
Return on Invested Capital (ROIC)
-31.26%-91.05%-52.98%-37.05%-42.74%-36.56%
Return on Capital Employed (ROCE)
-18.66%-58.14%-33.34%-21.20%-17.87%-18.21%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-7.43%-4.02%-13.70%-12.95%-10.00%-16.67%
Total Shareholder Return
-7.43%-4.02%-13.70%-12.95%-10.00%-16.67%
SEC Filings: 10-K · 10-Q